Anderson Hoagland & Co’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Anderson Hoagland & Co’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-16,080	Closed	-$533K	–	105
2015 Q1	$533K	Hold	16,080	–	–	0.31%	79
2014 Q4	$517K	Hold	16,080	–	–	0.31%	73
2014 Q3	$467K	Hold	16,080	–	–	0.29%	82
2014 Q2	$486K	Hold	16,080	–	–	0.31%	79
2014 Q1	$445K	Sell	16,080 -3,000	-16%	-$78.5K	0.3%	82
2013 Q4	$487K	Buy	19,080 +1,000	+6%	+$30.8K	0.34%	69
2013 Q3	$540K	Sell	18,080 -54,376	-75%	-$1.51M	0.37%	64
2013 Q2	$2.08M	Buy	+72,456	New	+$2M	2.51%	21

Other funds holding BRLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Anderson Hoagland & Co's BRLI Position: Q2 2015 in Review

Anderson Hoagland & Co sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q2 2015, closing a stake of 16,080 shares — an estimated $533K sold.

Anderson Hoagland & Co first reported a position in BRLI in Q2 2013 and held it in 8 quarters. The position peaked at $2.08M in Q2 2013. 183 funds tracked by Wall St. Rank hold BRLI as of Q2 2015.

Anderson Hoagland & Co reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q2 2015 after selling out during the quarter.
Anderson Hoagland & Co sold 16,080 BIO-REFERENCE LABS INC-NEW- shares in Q2 2015, an estimated $533K.
Anderson Hoagland & Co first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 8 quarters.
Anderson Hoagland & Co's BIO-REFERENCE LABS INC-NEW- position peaked at $2.08M in Q2 2013.
183 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q2 2015.

Based on Anderson Hoagland & Co's 13F filing for Q2 2015, filed 20 Jul 2015.